Patient Square Capital LP — Q1 2024 13F-HR

← Patient Square Capital LP

Q1 2024 · 13F-HR

Patient Square Capital LPholdings as filed

Filed 2024-05-14 · accession 0000950123-24-005073

$234.8M

Reported value

Positions

2024-03-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
G76279101	ROIV	ROIVANT SCIENCES LTD	$128.9M	54.9%	12,228,465	Common	SOLE
53635D202	LQDA	LIQUIDIA CORPORATION	$105.9M	45.1%	7,182,532	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.